| Literature DB >> 33801441 |
Sameeksha Chopra1,2,3,4, Zoë Myers1,2,3, Henna Sekhon1,2,3, Antoine Dufour1,2,3.
Abstract
Multiple sclerosis (MS) is a chronic inflammatory neurodegenerative autoimmune disease characterized by the aberrant infiltration of immune cells into the central nervous system (CNS) and by the loss of myelin. Sclerotic lesions and various inhibitory factors hamper the remyelination processes within the CNS. MS patients typically experience gradual cognitive and physical disabilities as the disease progresses. The etiology of MS is still unclear and emerging evidence suggests that microbiome composition could play a much more significant role in disease pathogenesis than was initially thought. Initially believed to be isolated to the gut microenvironment, we now know that the microbiome plays a much broader role in various tissues and is essential in the development of the immune system. Here, we present some of the unexpected roles that the microbiome plays in MS and discuss approaches for the development of next-generation treatment strategies.Entities:
Keywords: bacteria; central nervous system (CNS); immunity; microbiome; multiple sclerosis (MS); virus
Year: 2021 PMID: 33801441 PMCID: PMC7958632 DOI: 10.3390/ijms22052498
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923